Recently, CR Jiuchuang has received Drug Registration Certificate (Certificate No.: 2021S00714) for Mitoxantrone Hydrochloride Injection for Tracing (Trade name: Fu Ta Shu) issued by National Medical Product Administrative (NMPA).
Mitoxantrone Hydrochloride Injection for Tracing belongs to class 2 new drug, and was once enrolled in Major Projects of National Thirteenth Five-Year Key New Drug Innovation and Manufacturing Technologies. This product may be injected into adjacent tissues of tumors to target at local lymph nodes and stain them blue, so as to trace the lymph nodes; and so it can be used widely for tracing of those local draining lymph nodes in thyroid cancer surgeries. This product is the first product approved for tracing of local draining lymph nodes in thyroid cancer surgeries. With clinical verification, this product has good safety and good lymph node tracing effect, and shows no specific stain of parathyroid glands at the same time, so as to reduce inadvertent parathyroid excision rate significantly, with important clinical use value
Mitoxantrone Hydrochloride Injection for Lymph Node Tracing is an innovative product in the lymph node tracing field, and the gained drug registration certificate will help the Anti-Infection Business Division enrich its product pipelines, can promote transmission and development of the Anti-Infection Business Division.
